|
gptkbp:instanceOf
|
vaccine
|
|
gptkbp:activeIngredient
|
pneumococcal polysaccharide
|
|
gptkbp:administeredBy
|
separate syringe if given with other vaccines
|
|
gptkbp:age
|
adults 50 years and older
persons 2 years and older at increased risk
|
|
gptkbp:approvedBy
|
gptkb:FDA
1983
|
|
gptkbp:ATCCode
|
gptkb:J07AL01
|
|
gptkbp:boosterInterval
|
at least 5 years between doses
|
|
gptkbp:boosterRecommended
|
yes
|
|
gptkbp:brand
|
gptkb:Pneumovax_23
|
|
gptkbp:containsPreservative
|
no
|
|
gptkbp:contraindication
|
severe allergic reaction to previous dose
severe allergic reaction to vaccine component
|
|
gptkbp:countryOfOperation
|
gptkb:Australia
gptkb:Canada
gptkb:Japan
gptkb:United_Kingdom
gptkb:United_States
|
|
gptkbp:doseVolume
|
0.5 mL
|
|
gptkbp:form
|
solution for injection
|
|
gptkbp:genericName
|
gptkb:pneumococcal_polysaccharide_vaccine
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Pneumovax 23
|
|
gptkbp:indication
|
prevention of invasive pneumococcal disease
prevention of pneumococcal disease
prevention of bacteremia
prevention of meningitis
prevention of pneumonia
|
|
gptkbp:manufacturer
|
gptkb:Merck_&_Co.
|
|
gptkbp:notEffectiveAgainst
|
viral infections
non-pneumococcal bacteria
|
|
gptkbp:numberOfSerotypesCovered
|
23
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:prescriptionStatus
|
prescription only
|
|
gptkbp:protectedBy
|
gptkb:Streptococcus_pneumoniae
|
|
gptkbp:routeOfAdministration
|
intramuscular
subcutaneous
|
|
gptkbp:sideEffect
|
fever
muscle aches
injection site pain
redness
swelling
|
|
gptkbp:storage
|
2-8°C
|
|
gptkbp:synonym
|
gptkb:PPSV23
|
|
gptkbp:usedInChronicDisease
|
yes
|
|
gptkbp:usedInElderly
|
yes
|
|
gptkbp:usedInImmunocompromised
|
yes
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
yes
|
|
gptkbp:bfsParent
|
gptkb:MRK
|
|
gptkbp:bfsLayer
|
5
|